Edition:
United Kingdom

CRISPR Therapeutics AG (CRSP.OQ)

CRSP.OQ on NASDAQ Stock Exchange Global Market

39.56USD
25 Apr 2019
Change (% chg)

-- (--)
Prev Close
$39.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
204,428
52-wk High
$73.90
52-wk Low
$22.23

Select another date:

Tue, Apr 16 2019

BRIEF-Crispr Therapeutics And Vertex Announce FDA Fast Track Designation For CTX001 For Treatment Of Beta Thalassemia

* CRISPR THERAPEUTICS AND VERTEX ANNOUNCE FDA FAST TRACK DESIGNATION FOR CTX001 FOR THE TREATMENT OF BETA THALASSEMIA Source text for Eikon: Further company coverage:

Select another date: